Mercer Global Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Mercer Global Advisors Inc

  • $45.6 Billion
  • Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 25,773 shares of REGN stock, worth $18.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
25,773
Previous 24,319 5.98%
Holding current value
$18.1 Million
Previous $25.6 Million 6.0%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $1.49 Million - $1.75 Million
1,454 Added 5.98%
25,773 $27.1 Million
Q2 2024

Aug 12, 2024
BUY
$883.2 - $1071.19 $990,950 - $1.2 Million
1,122 Added 4.84%
24,319 $25.6 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $1.2 Million - $1.32 Million
1,328 Added 6.07%
23,197 $22.3 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $673,631 - $766,197
869 Added 4.14%
21,869 $19.2 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $1.19 Million - $1.45 Million
1,713 Added 8.88%
21,000 $17.3 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $618,126 - $733,199
883 Added 4.8%
19,287 $13.9 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $332,759 - $404,388
-489 Reduced 2.59%
18,404 $15.1 Million
Q4 2022

Feb 08, 2023
BUY
$705.89 - $766.39 $859,774 - $933,463
1,218 Added 6.89%
18,893 $13.6 Million
Q3 2022

Nov 15, 2022
BUY
$573.97 - $724.32 $849,475 - $1.07 Million
1,480 Added 9.14%
17,675 $12.2 Million
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $1.54 Million - $2.07 Million
2,806 Added 20.96%
16,195 $9.57 Million
Q1 2022

May 10, 2022
BUY
$595.12 - $698.43 $3.23 Million - $3.79 Million
5,423 Added 68.08%
13,389 $9.35 Million
Q4 2021

Feb 04, 2022
BUY
$543.48 - $670.97 $2.32 Million - $2.86 Million
4,264 Added 115.18%
7,966 $5.03 Million
Q3 2021

Nov 10, 2021
BUY
$574.03 - $680.96 $49,940 - $59,243
87 Added 2.41%
3,702 $2.24 Million
Q2 2021

Aug 10, 2021
SELL
$472.8 - $558.54 $1.16 Million - $1.37 Million
-2,447 Reduced 40.37%
3,615 $2.02 Million
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $763,908 - $937,422
1,710 Added 39.29%
6,062 $2.87 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $855,200 - $1.09 Million
1,788 Added 69.73%
4,352 $2.1 Million
Q3 2020

Dec 10, 2020
BUY
$544.75 - $658.21 $957,670 - $1.16 Million
1,758 Added 218.11%
2,564 $1.44 Million
Q2 2020

Aug 10, 2020
BUY
$493.32 - $643.92 $2,959 - $3,863
6 Added 0.75%
806 $503,000
Q1 2020

May 18, 2020
BUY
$336.18 - $494.43 $28,239 - $41,532
84 Added 11.73%
800 $391,000
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $196,277 - $269,581
716 New
716 $269,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email